The Role of T Helper 17 Cells and Other IL-17-Producing Cells in Bone Resorption and Remodeling

REFERENCES

• Raisz LG, Rodan GA. Pathogenesis of osteoporosis. Endocrinol Metab Clin North Am. 2003 Mar;32(1):15–24.
   PubMed Web of Science ®Google Scholar
• Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009 Sep;29(5):555–567.
   PubMed Web of Science ®Google Scholar
• Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008 Jun;29(4):403–440.
   PubMed Web of Science ®Google Scholar
• Dong C, Flavell RA. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res. 2000;2(3):179–188.
   PubMedGoogle Scholar
• Wynn TA. T(H)-17: a giant step from T(H)1 and T(H)2. Nat Immunol. 2005 Nov;6(11):1069–1070.
   PubMed Web of Science ®Google Scholar
• Jager A, Kuchroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol. 2010 Sep;72(3):173–184.
   PubMed Web of Science ®Google Scholar
• Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 2000 Jul 15;14(14):1693–1711.
   PubMed Web of Science ®Google Scholar
• Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006 Oct 2;203(10):2271–2279.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485–517.
   PubMed Web of Science ®Google Scholar
• Awasthi A, Riol-Blanco L, Jager A, et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol. 2009 May 15;182(10):5904–5908.
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005 Jan 17;201(2):233–240.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007 Jul 26;448(7152):484–487.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006 May 11;441(7090):235–238.
   PubMed Web of Science ®Google Scholar
• Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007 Mar 30;282(13):9358–9363.
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006 Nov 27;203(12):2673–2682.
   PubMed Web of Science ®Google Scholar
• Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795–823.
   PubMed Web of Science ®Google Scholar
• Kotake S, Nanke Y, Mogi M, et al. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol. 2005 Nov;35(11):3353–3363.
   PubMed Web of Science ®Google Scholar
• Giuliani N, Colla S, Sala R, et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood. 2002 Dec 15;100(13):4615–4621.
   PubMed Web of Science ®Google Scholar
• Li Y, Toraldo G, Li A, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007 May 1;109(9):3839–3848.
   PubMed Web of Science ®Google Scholar
• Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):125–130.
   PubMed Web of Science ®Google Scholar
• Sato K, Takayanagi H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006 Jul;18(4):419–426.
   PubMed Web of Science ®Google Scholar
• Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999 Nov 18;402(6759):304–309.
   PubMed Web of Science ®Google Scholar
• Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000 Nov 30;408(6812):600–605.
   PubMed Web of Science ®Google Scholar
• Adamopoulos IE, Bowman EP. Immune regulation of bone loss by Th17 cells. Arthritis Res Ther. 2008;10(5):225.
   PubMed Web of Science ®Google Scholar
• Duque G, Huang DC, Dion N, et al. Interferon-gamma plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res. 2011 Jul;26(7):1472–1483.
   PubMed Web of Science ®Google Scholar
• Sato K, Satoh T, Shizume K, et al. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice. Cancer Res. 1992 Jan 15;52(2):444–449.
   PubMed Web of Science ®Google Scholar
• Rifas L. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem. 2006 Jul 1;98(4):706–714.
   PubMed Web of Science ®Google Scholar
• van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology. 2001 Jul;103(3):255–261.
   PubMed Web of Science ®Google Scholar
• Grewal TS, Genever PG, Brabbs AC, Birch M, Skerry TM. Best5: a novel interferon-inducible gene expressed during bone formation. FASEB J. 2000 Mar;14(3):523–531.
   PubMed Web of Science ®Google Scholar
• Manoury-Schwartz B, Chiocchia G, Bessis N, et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol. 1997 Jun 1;158(11):5501–5506.
   PubMed Web of Science ®Google Scholar
• Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997 Jun 1;158(11): 5507–5513.
   PubMed Web of Science ®Google Scholar
• Park JS, Kwok SK, Lim MA, et al. STA-21, a promising STAT3 inhibitor that reciprocally regulates Th17 and Treg, inhibits osteoclastogenesis and alleviates autoimmune inflammation. Arthritis Rheum. 2013 Dec 10. [Epub ahead of print].
   Google Scholar
• Komatsu N, Okamoto K, Sawa S, et al. Pathogenic conversion of Foxp3(+) T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014 Jan;20(1):62–68.
   PubMed Web of Science ®Google Scholar
• Nam D, Mau E, Wang Y, et al. T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS One. 2012;7(6):e40044.
   PubMed Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999 May;103(9):1345–1352.
   PubMed Web of Science ®Google Scholar
• Adamopoulos IE, Chao CC, Geissler R, et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther. 2010;12(1):R29.
   PubMed Web of Science ®Google Scholar
• Lubberts E, van den Bersselaar L, Oppers-Walgreen B, et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol. 2003 Mar 1;170(5):2655–2662.
   PubMed Web of Science ®Google Scholar
• Nakashima T, Kobayashi Y, Yamasaki S, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000 Sep 7;275(3):768–775.
   PubMed Web of Science ®Google Scholar
• Yago T, Nanke Y, Ichikawa N, et al. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J Cell Biochem. 2009 Nov 1;108(4):947–955.
   PubMed Web of Science ®Google Scholar
• D'Amelio P, Grimaldi A, Bernabei P, Pescarmona GP, Isaia G. Immune system and bone metabolism: Does thymectomy influence postmenopausal bone loss in humans? Bone. 2006 Sep;39(3):658–665.
   PubMed Web of Science ®Google Scholar
• Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther. 2005;7(1):29–37.
   PubMed Web of Science ®Google Scholar
• Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003 Dec 1;171(11):6173–6177.
   PubMed Web of Science ®Google Scholar
• Pollinger B, Junt T, Metzler B, et al. Th17 cells, not IL-17+ gammadelta T cells, drive arthritic bone destruction in mice and humans. J Immunol. 2011 Feb 15;186(4):2602–2612.
   PubMed Web of Science ®Google Scholar
• Adamopoulos IE, Tessmer M, Chao CC, et al. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol. 2011 Jul 15;187(2):951–959.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Lubberts E, Joosten L, van Den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001;3(3):168–177.
   PubMedGoogle Scholar
• Dudler J, Renggli-Zulliger N, Busso N, Lotz M, So A. Effect of interleukin 17 on proteoglycan degradation in murine knee joints. Ann Rheum Dis. 2000 Jul;59(7):529–532.
   PubMed Web of Science ®Google Scholar
• Lubberts E, Joosten LA, van de Loo FA, Schwarzenberger P, Kolls J, van den Berg WB. Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm Res. 2002 Feb;51(2):102–104.
   PubMed Web of Science ®Google Scholar
• Koenders MI, Kolls JK, Oppers-Walgreen B, et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 2005 Oct;52(10):3239–3247.
   PubMed Web of Science ®Google Scholar
• Lubberts E, Koenders MI, Oppers-Walgreen B, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004 Feb;50(2):650–659.
   PubMed Web of Science ®Google Scholar
• Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem. 1998 Oct 16;273(42):27467–27473.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK). Arthritis Rheum. 1999 Nov;42(11):2399–2409.
   PubMed Web of Science ®Google Scholar
• Honorati MC, Bovara M, Cattini L, Piacentini A, Facchini A. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage. 2002 Oct;10(10):799–807.
   PubMed Web of Science ®Google Scholar
• Shen F, Ruddy MJ, Plamondon P, Gaffen SL. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol. 2005 Mar;77(3):388–399.
   PubMed Web of Science ®Google Scholar
• Ruddy MJ, Shen F, Smith JB, Sharma A, Gaffen SL. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol. 2004 Jul;76(1):135–144.
   PubMed Web of Science ®Google Scholar
• Kokubu T, Haudenschild DR, Moseley TA, Rose L, Reddi AH. Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing. J Histochem Cytochem. 2008 Feb;56(2):89–95.
   PubMed Web of Science ®Google Scholar
• Huang H, Kim HJ, Chang EJ, et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009 Oct;16(10):1332–1343.
   PubMed Web of Science ®Google Scholar
• Zhang F, Tanaka H, Kawato T, et al. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Biochimie. 2011 Feb;93(2):296–305.
   PubMed Web of Science ®Google Scholar
• Zhang F, Koyama Y, Sanuki R, et al. IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells. Arch Oral Biol. 2010 Sep;55(9):679–688.
   PubMed Web of Science ®Google Scholar
• Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 2001 Oct 1;20(19): 5332–5341.
   PubMed Web of Science ®Google Scholar
• Yago T, Nanke Y, Kawamoto M, et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther. 2007;9(5): R96.
   PubMed Web of Science ®Google Scholar
• Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005 Mar;22(3):285–294.
   PubMed Web of Science ®Google Scholar
• Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y. Resident Vdelta1 +gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol. 2007 Apr 1;178(7):4466–4472.
   PubMed Web of Science ®Google Scholar
• Lochner M, Peduto L, Cherrier M, et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t +T cells. J Exp Med. 2008 Jun 9;205(6):1381–1393.
   PubMed Web of Science ®Google Scholar
• Rachitskaya AV, Hansen AM, Horai R, et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol. 2008 Apr 15;180(8):5167–5171.
   PubMed Web of Science ®Google Scholar
• Buonocore S, Ahern PP, Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010 Apr 29;464(7293):1371–1375.
   PubMed Web of Science ®Google Scholar
• Suzuki E, Mellins ED, Gershwin ME, Nestle FO, Adamopoulos IE. The IL-23/IL-17 axis in psoriatic arthritis. Autoimmun Rev. 2014 Jan 11;13:496–502.
   PubMed Web of Science ®Google Scholar
• Quinn JM, Sims NA, Saleh H, et al. IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice. J Immunol. 2008 Oct 15;181(8):5720–5729.
   PubMed Web of Science ®Google Scholar
• Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253–278.
   PubMed Web of Science ®Google Scholar
• Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15:797–819.
   PubMed Web of Science ®Google Scholar
• Roodman GD. Interleukin-6: an osteotropic factor? J Bone Miner Res. 1992 May;7(5):475–478.
   PubMed Web of Science ®Google Scholar
• Rufo A, Del Fattore A, Capulli M, et al. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res. 2011 Aug;26(8):1891–1903.
   PubMed Web of Science ®Google Scholar
• Duplomb L, Baud'huin M, Charrier C, et al. Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3. Endocrinology. 2008 Jul;149(7):3688–3697.
   PubMed Web of Science ®Google Scholar
• Bakker AD, Kulkarni RN, Klein-Nulend J, Lems WF. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts. J Dent Res. 2014 Feb 3;93:394–399.
   PubMed Web of Science ®Google Scholar
• Yokota K, Sato K, Miyazaki T, et al. Combination of tumor necrosis factor alpha and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. Arthritis Rheumatol. 2014 Jan;66(1):121–129.
   Web of Science ®Google Scholar
• Wallace A, Cooney TE, Englund R, Lubahn JD. Effects of interleukin-6 ablation on fracture healing in mice. J Orthop Res. 2011 Sep;29(9):1437–1442.
   PubMed Web of Science ®Google Scholar
• Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MP. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone. 2007 Dec;41(6):928–936.
   PubMed Web of Science ®Google Scholar
• Mori G, D'Amelio P, Faccio R, Brunetti G. The Interplay between the bone and the immune system. Clin Dev Immunol. 2013;2013:720504.
   PubMed Web of Science ®Google Scholar
• Gilbert L, He X, Farmer P, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology. 2000 Nov;141(11):3956–3964.
   PubMed Web of Science ®Google Scholar
• Ghali O, Chauveau C, Hardouin P, Broux O, Devedjian JC. TNF-alpha's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression. J Bone Miner Res. 2010 Jul;25(7):1616–1626.
   PubMed Web of Science ®Google Scholar
• Gilbert L, He X, Farmer P, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem. 2002 Jan 25;277(4):2695–2701.
   PubMed Web of Science ®Google Scholar
• Hu M, Bassett JH, Danks L, et al. Activated invariant NKT cells regulate osteoclast development and function. J Immunol. 2011 Mar 1;186(5):2910–2917.
   PubMed Web of Science ®Google Scholar
• Ellabban A, Kamel S, Ahmed S, Osman A. Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis. Rheumatol Int. 2012 2012/06/01;32(6):1589–1596.
   PubMed Web of Science ®Google Scholar
• Hein G, Meister M, Oelzner P, Franke S. sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis. Rheumatol Int. 2008 2008/06/01;28(8):765–769.
   PubMed Web of Science ®Google Scholar
• Gilbert LC, Chen H, Lu X, Nanes MS. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts. Bone. 2013;56(1):174–183.
   PubMed Web of Science ®Google Scholar
• Zhou FH, Foster BK, Zhou XF, Cowin AJ, Xian CJ. TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res. 2006 Jul;21(7):1075–1088.
   PubMed Web of Science ®Google Scholar
• Chen Y, Whetstone HC, Lin AC, et al. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med. 2007 Jul 31;4(7):e249.
   PubMed Web of Science ®Google Scholar
• Gerstenfeld LC, Cho TJ, Kon T, et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res. 2003 Sep;18(9):1584–1592.
   PubMed Web of Science ®Google Scholar
• Roark CL, French JD, Taylor MA, Bendele AM, Born WK, O'Brien RL. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J Immunol. 2007 Oct 15;179(8):5576–5583.
   PubMed Web of Science ®Google Scholar
• Peterman GM, Spencer C, Sperling AI, Bluestone JA. Role of gamma delta T cells in murine collagen-induced arthritis. J Immunol. 1993 Dec 1;151(11):6546–6558.
   PubMed Web of Science ®Google Scholar
• Arai K, Yamamura S, Hanyu T, et al. Extrathymic differentiation of resident T cells in the joints of mice with collagen-induced arthritis. J Immunol. 1996 Dec 1;157(11):5170–5177.
   PubMed Web of Science ®Google Scholar
• Ito Y, Usui T, Kobayashi S, et al. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. 2009 Aug;60(8):2294–2303.
   PubMed Web of Science ®Google Scholar
• Holoshitz J, Koning F, Coligan JE, De Bruyn J, Strober S. Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature. 1989 May 18;339(6221):226–229.
   PubMed Web of Science ®Google Scholar
• Kjeldsen-Kragh J, Quayle A, Kalvenes C, et al. T gamma delta cells in juvenile rheumatoid arthritis and rheumatoid arthritis. In the juvenile rheumatoid arthritis synovium the T gamma delta cells express activation antigens and are predominantly V delta 1+, and a significant proportion of these patients have elevated percentages of T gamma delta cells. Scand J Immunol. 1990 Dec;32(6):651–659.
   PubMed Web of Science ®Google Scholar
• Brennan FM, Londei M, Jackson AM, et al. T cells expressing gamma delta chain receptors in rheumatoid arthritis. J Autoimmun. 1988 Aug;1(4):319–326.
   PubMed Web of Science ®Google Scholar
• Hayday AC. γδ T Cells and the Lymphoid Stress-Surveillance Response. Immunity. 2009;31(2):184–196.
   PubMed Web of Science ®Google Scholar
• Strid J, Roberts SJ, Filler RB, et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol. 2008 Feb;9(2):146–154.
   PubMed Web of Science ®Google Scholar
• Ray K. Experimental arthritis. Tipping the balance: conversion of Foxp3+ T cells to TH17 cells is crucial in autoimmune arthritis. Nat Rev Rheumatol. 2014 Feb;10(2):63.
   PubMedGoogle Scholar
• Komatsu N, Okamoto K, Sawa S, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014 Jan;20(1):62–68.
   PubMed Web of Science ®Google Scholar
• Buchwald ZS, Kiesel JR, Yang C, DiPaolo R, Novack DV, Aurora R. Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice. Bone. 2013 Sep;56(1):163–173.
   PubMed Web of Science ®Google Scholar
• Choi Y, Woo KM, Ko SH, et al. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Eur J Immunol. 2001 Jul;31(7):2179–2188.
   PubMed Web of Science ®Google Scholar
• Schlegel PM, Steiert I, Kotter I, Muller CA. B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls. PLoS One. 2013;8(12):e82580.
   PubMed Web of Science ®Google Scholar
• Bermejo DA, Jackson SW, Gorosito-Serran M, et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol. 2013 May;14(5):514–522.
   PubMed Web of Science ®Google Scholar
• Leon B, Lund FE. IL-17-producing B cells combat parasites. Nat Immunol. [News and Views]. 2013;14(5):419–421.
   PubMed Web of Science ®Google Scholar
• Miyaura C, Onoe Y, Inada M, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9360–9365.
   PubMed Web of Science ®Google Scholar
• Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol. 2001 Oct 15;167(8):4710–4718.
   PubMed Web of Science ®Google Scholar
• O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol. 2005 Mar 15;174(6):3781–3788.
   PubMed Web of Science ®Google Scholar
• Wilson CL, Hine DW, Pradipta A, et al. Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation. Immunology. 2012 Apr;135(4):344–354.
   PubMed Web of Science ®Google Scholar
• Choi Y, Kim JJ. B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis. Exp Mol Med. 2003 Oct 31;35(5):385–392.
   PubMed Web of Science ®Google Scholar
• Chenu C, Pfeilschifter J, Mundy GR, Roodman GD. Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5683–5687.
   PubMed Web of Science ®Google Scholar
• Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med. 1996 Oct;2(10):1132–1136.
   PubMed Web of Science ®Google Scholar
• Thirunavukkarasu K, Miles RR, Halladay DL, et al. Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects. J Biol Chem. 2001 Sep 28;276(39):36241–36250.
   PubMed Web of Science ®Google Scholar
• Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J. 2005 Jan;25(1):159–172.
   PubMed Web of Science ®Google Scholar
• Linden A, Adachi M. Neutrophilic airway inflammation and IL-17. Allergy. 2002 Sep;57(9):769–775.
   PubMed Web of Science ®Google Scholar
• Forlow SB, Schurr JR, Kolls JK, Bagby GJ, Schwarzenberger PO, Ley K. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood. 2001 Dec 1;98(12):3309–3314.
   PubMed Web of Science ®Google Scholar
• Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol. 2003 Feb 15;170(4):2106–2112.
   PubMed Web of Science ®Google Scholar
• Yu JJ, Ruddy MJ, Wong GC, et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood. 2007 May 1;109(9):3794–3802.
   PubMed Web of Science ®Google Scholar
• Chakravarti A, Raquil MA, Tessier P, Poubelle PE. Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. Blood. 2009 Aug 20;114(8):1633–1644.
   PubMed Web of Science ®Google Scholar
• Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M. Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett. 2004 Jul 15;94(3):239–246.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1.
   PubMed Web of Science ®Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003 May 15;423(6937):337–342.
   PubMed Web of Science ®Google Scholar
• Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011 Feb 25;34(2):149–162.
   PubMed Web of Science ®Google Scholar
• Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010 Mar;129(3):311–321.
   PubMed Web of Science ®Google Scholar
• Ge S, Hertel B, Susnik N, et al. Interleukin 17 receptor a modulates monocyte subsets and macrophage generation in vivo. PLoS One. 2014 Jan 15;9(1):e85461.
   PubMed Web of Science ®Google Scholar
• Barin JG, Baldeviano GC, Talor MV, et al. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol. 2012 Mar;42(3):726–736.
   PubMed Web of Science ®Google Scholar
• Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis. 1994 Jan;53(1):39–44.
   PubMed Web of Science ®Google Scholar
• Rivollier A, Mazzorana M, Tebib J, et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood. 2004 Dec 15;104(13):4029–4037.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Chen B, Yan F, et al. Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases. Biomed Res Int. 2014;2014:284836.
   PubMed Web of Science ®Google Scholar
• MacKenzie KF, Pattison MJ, Arthur JS. Transcriptional regulation of IL-10 and its cell-specific role in vivo. Crit Rev Immunol. 2014;34(4):315–345.
   PubMed Web of Science ®Google Scholar
• Evans HG, Roostalu U, Walter GJ, et al. TNF-alpha blockade induces IL-10 expression in human CD4+ T cells. Nat Commun. 2014 Feb 4;5:3199.
   PubMedGoogle Scholar
• LeibundGut-Landmann S, Gross O, Robinson MJ, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007 Jun;8(6):630–638.
   PubMed Web of Science ®Google Scholar
• Bailey SL, Schreiner B, McMahon EJ, Miller SD. CNS myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol. 2007 Feb;8(2):172–180.
   PubMed Web of Science ®Google Scholar
• Estrada-Capetillo L, Hernandez-Castro B, Monsivais-Urenda A, et al. Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol. 2013;2013:584303.
   PubMed Web of Science ®Google Scholar
• Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225–274.
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001 May 15;97(10):3146–3151.
   PubMed Web of Science ®Google Scholar
• Balato A, Unutmaz D, Gaspari AA. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol. 2009 Jul;129(7):1628–1642.
   PubMed Web of Science ®Google Scholar
• Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol. 2004 Mar;4(3):231–237.
   PubMed Web of Science ®Google Scholar
• Michel ML, Mendes-da-Cruz D, Keller AC, et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19845–19850.
   PubMed Web of Science ®Google Scholar
• Passos ST, Silver JS, O'Hara AC, Sehy D, Stumhofer JS, Hunter CA. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol. 2010 Feb 15;184(4):1776–1783.
   PubMed Web of Science ®Google Scholar
• Grajewski RS, Hansen AM, Agarwal RK, et al. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J Immunol. 2008 Oct 1;181(7):4791–4797.
   PubMed Web of Science ®Google Scholar
• Tak PP, Kummer JA, Hack CE, et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum. 1994 Dec;37(12):1735–1743.
   PubMed Web of Science ®Google Scholar
• de Matos CT, Berg L, Michaelsson J, Fellander-Tsai L, Karre K, Soderstrom K. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology. 2007 Oct;122(2):291–301.
   PubMed Web of Science ®Google Scholar
• Pridgeon C, Lennon GP, Pazmany L, Thompson RN, Christmas SE, Moots RJ. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype. Rheumatology (Oxford). 2003 Jul;42(7):870–878.
   PubMed Web of Science ®Google Scholar